Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

American Journal of Hematology

Volumn 91, Issue 10, 2016, Pages 995-1001

  Efficace, Fabio ^a   Mandelli, Franco ^a   Fazi, Paola ^a   Santoro, Cristina ^b   Gaidano, Gianluca ^c   Cottone, Francesco ^a   Borchiellini, Alessandra ^d   Carpenedo, Monica ^e   Simula, Maria Pina ^f   Di Giacomo, Valeria ^g   Bergamaschi, Micaela ^h   Vincelli, Iolanda Donatella ⁱ   Rodeghiero, Francesco ^j   Ruggeri, Marco ^k   Scaramucci, Laura ^l   Rambaldi, Alessandro ^m   Cascavilla, Nicola ⁿ   Forghieri, Fabio ^o   Petrungaro, Annamaria ^p   Ditonno, Paolo ^q   Caocci, Giovanni ^r   Cirrincione, Sonia ^s   Mazzucconi, Maria Gabriella ^b   more..

^a Data Center and Health Outcomes Research Unit   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d Hemostasis Thrombosis Unit and Hemophilia Centre   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

^f Ospedale Oncologico A Businco   (Italy)

^g Azienda Ospedaliera Papardo   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^j Fondazione Progetto Ematologia   (Italy)

^k SAN BORTOLO HOSPITAL   (Italy)

^l S EUGENIO HOSPITAL   (Italy)

^m UNIVERSITY OF MILAN   (Italy)

ⁿ CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^o UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^p UNIVERSITY OF MESSINA   (Italy)

^q DI VENERE HOSPITAL   (Italy)

^r UNIVERSITY OF CAGLIARI   (Italy)

^s TREVIGLIO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; EMOTIONAL DISORDER; FATIGUE; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; POPULATION; PRIORITY JOURNAL; PROPENSITY SCORE; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; SHORT FORM 36; SOCIAL DISABILITY; SOCIAL INTERACTION; VULNERABLE POPULATION;

EID: 84990243932     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24463     Document Type: Article

References (29)

1. Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117:4190–4207.
2. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2386–2393.
3. Kuter DJ, Rummel M, Boccia R, et al. Romiplostim or standard of care in patients with immune thrombocytopenia. New Engl J Med 2010;363:1889–1899.
4. George JN, Mathias SD, Go RS, et al. Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: Results from two randomized, placebo-controlled trials. Br J Haematol 2009;144:409–415.
5. Kuter DJ, Mathias SD, Rummel M, et al. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. Am J Hematol 2012;87:558–561.
6. Kuter DJ, Bussel JB, Lyons RM, et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: A double-blind randomised controlled trial. Lancet 2008; 371:395–403.
7. McMillan R, Bussel JB, George JN, et al. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 2008;83:150–154.
8. Zhou Z, Yang L, Chen Z, et al. Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: A cross-sectional survey in China. Eur J Haematol 2007;78:518–523.
9. Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 2011;86:420–429.
10. Sarpatwari A, Watson S, Erqou S, et al. Health-related lifestyle in adults and children with primary immune thrombocytopenia (ITP). Br J Haematol 2010;151:189–191.
11. Matzdorff AC, Arnold G, Salama A, et al. Advances in ITP-therapy and quality of life—A patient survey. PLoS One 2011;6:e27350.
12. Suvajdzic N, Zivkovic R, Djunic I, et al. Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia. Platelets 2014;25:467–469.
13. Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health 2005;27:281–291.
14. Apolone G, Mosconi P. The Italian SF-36 Health Survey: Translation, validation and norming. J Clin Epidemiol 1998;51:1025–1036.
15. Apolone G, Filiberti A, Cifani S, et al. Evaluation of the EORTC QLQ-C30 questionnaire: A comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998;9:549–557.
16. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Medical Care 1992;30:473–483.
17. Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315–325.
18. Schwarz R, Krauss O, Hinz A. Fatigue in the general population. Onkologie 2003;26:140–144.
19. National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology. Cancer-related fatigue. V.1.2016.
20. Khellaf M, Michel M, Schaeffer A, et al. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. Haematologica 2005;90:829–832.
21. Berkman LF, Glass T, Brissette I, et al. From social integration to health: Durkheim in the new millennium. Soc Sci Med 2000;51:843–857.
22. Zimet GD, Powell SS, Farley GK, et al. Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess 1990;55:610–617.
23. Cottone F, Efficace F, Apolone G, et al. The added value of propensity score matching when using health-related quality of life reference data. Stat Med 2013;32:5119–5132.
24. Apolone G MP, Ware J. Questionario sullo stato di salute SF-36. Manuale d'uso e guida all'interpretazione dei risultati Versione Italiana Guerini e Associati Editore, Milan, 1997.
25. Sloan JST, Vargas-Chanes D, et al. Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials. Drug Inf J 2003;37:23–31.
26. Snyder CF, Mathias SD, Cella D, et al. Health-related quality of life of immune thrombocytopenic purpura patients: Results from a web-based survey. Curr Med Res Opin 2008;24:2767–2776.
27. Mathias SD, Bussel JB, George JN, et al. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: Psychometric testing in an open-label clinical trial. Clin Ther 2007;29:950–962.
28. Newland A, Godeau B, Priego V, et al. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: Final results from a phase 2 study. Br J Haematol 2016;172:262–273.
29. Efficace F, Baccarani M, Breccia M, et al. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia 2013;27:1511–1519.